The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GlaxoSmithKline; Hexal; Janssen-Cilag; Medac; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Amgen; Celgene; Eisai; Genomic Health; Janssen-Cilag; Pierre Fabre

Changes in circulating tumor cell counts during the course of chemotherapy in women with high-risk early breast cancer.
 
Marie Lena Johanna Tzschaschel
No Relationships to Disclose
 
Brigitte Kathrin Rack
Research Funding - AstraZeneca; Chugai Pharma; Janssen; Lilly; Novartis; Sanofi
 
Ulrich Andergassen
No Relationships to Disclose
 
Thomas W. P. Friedl
Honoraria - Eisai
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Chugai Pharma; Lilly; Novartis; Sanofi
Research Funding - AstraZeneca; Chugai Pharma; Lilly; Novartis; Sanofi
 
Volkmar Müller
No Relationships to Disclose
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; Novartis; Roche
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; PharmaMar; Roche
Research Funding - Novartis
 
Klaus Pantel
Honoraria - Veridex
Research Funding - Veridex
 
Jörg Gade
No Relationships to Disclose
 
Ralf Lorenz
No Relationships to Disclose
 
Mahdi Rezai
No Relationships to Disclose
 
Hans Tesch
No Relationships to Disclose
 
Ulrike Soeling
No Relationships to Disclose
 
Elisabeth Katharina Trapp
No Relationships to Disclose
 
Sven Mahner
Honoraria - AstraZeneca; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Christian Schindlbeck
No Relationships to Disclose
 
Werner Lichtenegger
No Relationships to Disclose
 
Matthias W. Beckmann
Consulting or Advisory Role - Novartis; Sanofi
Research Funding - AstraZeneca; Chugai Pharma; Lilly; Novartis; Sanofi
 
Peter A. Fasching
Honoraria - Amgen; GlaxoSmithKline; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Novartis; Pfizer; Roche; Teva
Speakers' Bureau - Amgen; GlaxoSmithKline; Novartis; Pfizer; Roche; Teva
Research Funding - Amgen (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Wolfgang Janni
Honoraria - Janssen Diagnostics
Consulting or Advisory Role - Janssen Diagnostics
Research Funding - Janssen Diagnostics